Total planned funding: $2,098,753,051
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $2,098,753,051 |
Organizational Types
University | $504,751,989 |
NGO | $445,520,164 |
Private Contractor | $395,239,292 |
Unknown | $337,043,537 |
FBO | $148,329,882 |
Own Agency | $146,290,491 |
Implementing Agency | $70,787,806 |
Other USG Agency | $38,389,890 |
Host Country Government Agency | $10,500,000 |
Multi-lateral Agency | $1,900,000 |
Program Areas
Treatment | $844,575,245 |
Care | $416,923,842 |
Governance and Systems | $342,335,030 |
Prevention | $307,146,851 |
Management and Operations | $100,953,415 |
Testing | $86,818,668 |
Budget Codes
HTXD: Treatment: ARV Drugs | $468,056,448 |
HTXS: Treatment: Adult Treatment | $354,567,587 |
HKID: Care: Orphans and Vulnerable Children | $178,997,517 |
HLAB: Laboratory Infrastructure | $156,531,768 |
HBHC: Care: Adult Care and Support | $154,523,762 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $105,522,645 |
HVMS: Management and Operations | $100,953,415 |
HVSI: Strategic Information | $95,579,569 |
OHSS: Health Systems Strengthening | $90,223,693 |
HVCT: Testing: HIV Testing and Counseling | $86,818,668 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $84,839,482 |
HVOP: Sexual Prevention: Other Sexual Prevention | $69,594,224 |
HVTB: Care: TB/HIV | $67,956,804 |
HMBL: Biomedical Prevention: Blood Safety | $29,535,004 |
PDTX: Treatment: Pediatric Treatment | $21,951,210 |
HMIN: Biomedical Prevention: Injection Safety | $17,615,496 |
PDCS: Care: Pediatric Care and Support | $15,445,759 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $40,000 |
Top Partner Programs
Not Available:
$353,154,525
Countries/Regions
FHI 360:
$229,020,466
Countries/Regions
University of Maryland:
$207,144,446
Countries/Regions
Harvard University:
$178,202,827
Countries/Regions